Chronic pain has a high prevalence in the aging population. Strong opioids also should be considered in older people for the treatment of moderate to severe pain or for pain that impairs functioning and the quality of life. This study aimed to assess the efficacy and safety of the direct switch to low-dose strong opioids (World Health Organization-Step III drugs) in elderly, opioid-naive patients.

Lazzari, M., Marcassa, C., Natoli, S., Carpenedo, R., Caldarulo, C., Silvi, M.B., et al. (2016). Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-step i drugs in elderly patients with chronic pain at high risk of early opioid discontinuation. CLINICAL INTERVENTIONS IN AGING, 11, 641-649 [10.2147/CIA.S105821].

Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-step i drugs in elderly patients with chronic pain at high risk of early opioid discontinuation

LAZZARI, MARZIA;NATOLI, SILVIA;SILVI, MARIA BEATRICE;DAURI, MARIO
2016

Abstract

Chronic pain has a high prevalence in the aging population. Strong opioids also should be considered in older people for the treatment of moderate to severe pain or for pain that impairs functioning and the quality of life. This study aimed to assess the efficacy and safety of the direct switch to low-dose strong opioids (World Health Organization-Step III drugs) in elderly, opioid-naive patients.
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/41 - Anestesiologia
English
Con Impact Factor ISI
chronic pain; elderly; naloxone; opioid; oxycodone
Lazzari, M., Marcassa, C., Natoli, S., Carpenedo, R., Caldarulo, C., Silvi, M.B., et al. (2016). Switching to low-dose oral prolonged-release oxycodone/naloxone from WHO-step i drugs in elderly patients with chronic pain at high risk of early opioid discontinuation. CLINICAL INTERVENTIONS IN AGING, 11, 641-649 [10.2147/CIA.S105821].
Lazzari, M; Marcassa, C; Natoli, S; Carpenedo, R; Caldarulo, C; Silvi, Mb; Dauri, M
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
switching to low dose....pdf

accesso aperto

Licenza: Creative commons
Dimensione 1.56 MB
Formato Adobe PDF
1.56 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/2108/166565
Citazioni
  • ???jsp.display-item.citation.pmc??? 4
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 5
social impact